Literature DB >> 17957397

Radiosurgery in the treatment of brain metastases: critical review regarding complications.

Marcos Vinícius Calfat Maldaun1, Paulo Henrique Pires Aguiar, Frederick Lang, Dima Suki, David Wildrick, Raymond Sawaya.   

Abstract

Stereotactic radiosurgery (SRS) has been described as an effective treatment option for brain metastases. In general, SRS has been indicated for the treatment of lesions smaller than 3 cm in maximum diameter and for lesions considered not surgically treatable, owing to the patient's clinical status or because the lesion was located in or near eloquent brain areas. In several studies, SRS has been associated with clinical and radiographic improvement of the lesions and has been compared with surgery as the modality of choice for brain metastases. Beyond the high rate of local disease control with SRS, the few complications that have been described occurred mainly in the acute post treatment period. Most publications have addressed the outcome and effectiveness of this treatment modality but have not critically analyzed long-term complications, steroid dependency, or results relating to specific brain locations. It is important to understand the radiobiologic effects of a well-demarcated high dose of radiation on the brain lesion, controlling the tumor growth and not causing significant alteration of the related brain region, especially in an area controlling eloquent function.

Entities:  

Mesh:

Year:  2007        PMID: 17957397     DOI: 10.1007/s10143-007-0110-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  70 in total

1.  Analysis of related factors in complications of stereotactic radiosurgery in intracranial tumors.

Authors:  Y Liu; S Xiao; M Liu; G Li; D Wang; J He; B Hu; D Zu
Journal:  Stereotact Funct Neurosurg       Date:  2000       Impact factor: 1.875

2.  Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy.

Authors:  Imjai Chitapanarux; Bryan Goss; Roy Vongtama; Leonardo Frighetto; Antonio De Salles; Michael Selch; Michael Duick; Timothy Solberg; Robert Wallace; Cynthia Cabatan-Awang; Judith Ford
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

3.  Resection of brain metastases previously treated with stereotactic radiosurgery.

Authors:  Giacomo G Vecil; Dima Suki; Marcos V C Maldaun; Frederick F Lang; Raymond Sawaya
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

4.  Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?

Authors:  C Nieder; U Nestle; B Motaref; K Walter; M Niewald; K Schnabel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

5.  Computer simulation of cytotoxic and vascular effects of radiosurgery in solid and necrotic brain metastases.

Authors:  M Kocher; H Treuer; J Voges; M Hoevels; V Sturm; R P Müller
Journal:  Radiother Oncol       Date:  2000-02       Impact factor: 6.280

6.  Gamma knife radiosurgery for patients with multiple cerebral metastases.

Authors:  B E Lippitz; T Kraepelien; K Hautanen; M Ritzling; T Rähn; E Ulfarsson; J Boethius
Journal:  Acta Neurochir Suppl       Date:  2004

7.  Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.

Authors:  Vitaly E Siomin; Michael A Vogelbaum; Andrew A Kanner; Shih-Yuan Lee; John H Suh; Gene H Barnett
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Direct costs of microsurgical management of radiosurgically amenable intracranial pathology in Germany: an analysis of meningiomas, acoustic neuromas, metastases and arteriovenous malformations of less than 3 cm in diameter.

Authors:  G Wellis; R Nagel; C Vollmar; H-J Steiger
Journal:  Acta Neurochir (Wien)       Date:  2003-04       Impact factor: 2.216

9.  In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts.

Authors:  J A Thomson; P G Parsons; R A Sturm
Journal:  Pigment Cell Res       Date:  1993-02

Review 10.  Update of stereotactic radiosurgery for brain tumors.

Authors:  John H Suh; Michael A Vogelbaum; Gene H Barnett
Journal:  Curr Opin Neurol       Date:  2004-12       Impact factor: 5.710

View more
  9 in total

1.  Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Authors:  Kazuhiro Ohtakara; Shinya Hayashi; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama; Hiroaki Hoshi
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

2.  Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen.

Authors:  Che-Chuan Wang; Scott R Floyd; Chin-Hong Chang; Peter C Warnke; Chung-Ching Chio; Ekkehard M Kasper; Anand Mahadevan; Eric T Wong; Clark C Chen
Journal:  J Neurooncol       Date:  2011-08-31       Impact factor: 4.130

3.  Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases.

Authors:  Maximilian I Ruge; Martin Kocher; Mohammad Maarouf; Christina Hamisch; Harald Treuer; Jürgen Voges; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2010-12-22       Impact factor: 3.621

Review 4.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

5.  Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases.

Authors:  Maximilian I Ruge; Philipp Kickingereder; Stefan Grau; Mauritius Hoevels; Harald Treuer; Volker Sturm
Journal:  J Neurooncol       Date:  2011-04-11       Impact factor: 4.130

6.  Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Authors:  Riccardo Soffietti; Ufuk Abacioglu; Brigitta Baumert; Stephanie E Combs; Sara Kinhult; Johan M Kros; Christine Marosi; Philippe Metellus; Alexander Radbruch; Salvador S Villa Freixa; Michael Brada; Carmine M Carapella; Matthias Preusser; Emilie Le Rhun; Roberta Rudà; Joerg C Tonn; Damien C Weber; Michael Weller
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

7.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

8.  Treatment of malignant tumors of the skull base with multi-session radiosurgery.

Authors:  Nicholas D Coppa; Daniel M S Raper; Ying Zhang; Brian T Collins; K William Harter; Gregory J Gagnon; Sean P Collins; Walter C Jean
Journal:  J Hematol Oncol       Date:  2009-04-02       Impact factor: 17.388

9.  Stereotactic radiosurgery boost to the resection cavity for cerebral metastases: Report of overall survival, complications, and corticosteroid protocol.

Authors:  Robert G Kellogg; David C Straus; Mehee Choi; Thymur A Chaudhry; Aidnag Z Diaz; Lorenzo F Muñoz
Journal:  Surg Neurol Int       Date:  2013-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.